Sencar ME, Sakiz D, Calapkulu M, Hepsen S, Kizilgul M, Ozturk IU, et al
The data comes from GoodRx's new Weight Loss Medications Tracker, which examines fill trends and spending patterns in the U.S
For example, Novo Nordisk is exploring semaglutide in large-scale clinical trials for Alzheimers, while other biotech startups are assessing GLP-1 analogs in treating opioid dependency
Tirzepatide did not increase the odds of hypoglycaemia but was associated with increased incidence of gastrointestinal adverse events
Its available in four dosage strengths, including 1.5 mg, 4 mg, 9 mg, and 25 mg
Works through the central nervous system rather than peripheral vascular mechanismsaddressing sexual desire at its neurological source for both psychological and physiological effects